Credit Suisse Reiterates Underperform on Aveanna Healthcare Hldgs, Maintains $1 Price Target
Portfolio Pulse from richadhand@benzinga.com
Credit Suisse analyst A.J. Rice has reiterated an 'Underperform' rating on Aveanna Healthcare Hldgs (NASDAQ:AVAH) and maintained a $1 price target.
August 11, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Credit Suisse has reiterated an 'Underperform' rating on Aveanna Healthcare Hldgs, maintaining a $1 price target.
The 'Underperform' rating from Credit Suisse suggests that the analyst expects Aveanna Healthcare Hldgs to underperform the market or its sector in the short term. This could potentially lead to a decrease in the stock's price. The maintained price target of $1 also indicates that the analyst does not foresee significant upside potential in the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100